Trial intelligence / Profile preview

Humira in refractory non-infectious uveitis

NCT00525902Phase 2Completed

Sponsor
Oregon Health & Science University
Start
Jan 2008
Primary completion
Sep 2010
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of adalimumab in noninfectious uveitis (NIU), sponsored by Oregon Health & Science University. Started Jan 2008; status: completed.

02

Drugs

03

Conditions

noninfectious uveitis (NIU)

Beyond the preview

Go deeper on NCT00525902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call